Drugs / Bacillus clausii
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03683927 | Jan 2018 → Jan 2020 | respiratory tract infectious disorder | Universidad Nacional Autonoma de Mexico | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03359499 | Aug → Oct 2017 | irritable bowel syndrome | Hospital Britanico | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06594822 | Aug 2023 → Jan 2024 | rheumatoid arthritis | King Edward Medical University | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT02169817 | Jul 2014 → Jan 2016 | gastroenteritis | Sanofi | Completed | No outcome recorded |
| Phase 4 | NCT00424905 | Dec 2006 → Dec 2007 | digestive system disorder | Sanofi | Completed | No outcome recorded |
| Phase 4 | NCT00331994 | Apr 2006 → Jul 2008 | irritable bowel syndrome | Sanofi | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT07164781 | Apr → Sep 2025 overdue | diarrheal disease, urinary tract infection | Benha University | Enrolling by invitation | No outcome recorded |
| — | NCT06887374 | Mar → Sep 2024 | acute diarrhea | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT06540209 | Apr → Sep 2023 | acute diarrhea | RESnTEC, Institute of Research | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00457353 Comparator | Mar → Dec 2007 | gastroenteritis | Sanofi | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03539913 Comparator | Jun 2017 → Jun 2018 | gastroenteritis | Biocodex | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07660367 Comparator | Aug → Oct 2026 expected | acute diarrhea | Children Hospital and Institute of Child Health, Lahore | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacillus clausii | “This randomized controlled trial will compare Bacillus clausii (Enterogermina) and a multistrain probiotic preparation (Ecotec) in children aged 1-5 years with acute watery diarrhea.” NCT07660367 ↗11“Bacillus clausii, 5ml ampule containing 2 billion spores, given orally once daily” NCT06594822 ↗ |
| Known as | Enterogermina | “This randomized controlled trial will compare Bacillus clausii (Enterogermina) and a multistrain probiotic preparation (Ecotec) in children aged 1-5 years with acute watery diarrhea.” NCT07660367 ↗2“Enterogermina® vials containing 2×109 spores of polyantibiotic resistant Bacillus clausii (test drug)” NCT00424905 ↗ “The (Test group) will receive bacillus clausii (Enterogermina) 4 billion every 12h.” NCT07164781 ↗ |
| Modality | Other / unclassified | “Bacillus clausii probiotic strain” NCT00457353 ↗ |
| Route | Oral | “Administration of oral rehydration therapy with Bacillus clausii probiotic strain” NCT00457353 ↗ |